1-[[4-(3-METHOXYPROPOXY)-3-METHYL-2-PYRIDINYL]METHYL]-2-[[[4-(3-METHOXYPROPOXY)-3-METHYL-2-PYRIDINYL]METHYL]SULFINYL]-1H-BENZIMIDAZOLE

This compound is an active pharmaceutical ingredient impurity, characterized as a benzimidazole derivative with sulfoxide and pyridine substituents. It is a high-molecular-weight, lipophilic, and non-basic compound containing multiple ether linkages and aromatic rings.